Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Rasheda Ali Joins Moving Day® Tampa

Rasheda Ali Joins Tampa Bay Residents to Get "Moving" for Parkinson's Disease

TAMPA, FL — The National Parkinson Foundation (NPF) today announced that Tampa will be a host city for Moving Day ®—a grassroots campaign that spotlights Parkinson's disease (PD) across cities in the Unites States.  The event will be held on Saturday, April 11, 2015—World Parkinson's Day—from 9 a.m. to 12:30 p.m. at the University of South Florida and will raise awareness and funding to improve the lives of patients and families affected by the disease in the Tampa Bay community. 

The National Parkinson Foundation is also pleased to welcome Rasheda Ali to Moving Day ® Tampa Bay as a participant and special guest of the event. 

"As an advocate and family member of one touched by Parkinson's, I believe in what the National Parkinson Foundation's Moving Day ® event has accomplished," says Ali. "This inspiring event empowers individuals and families to meet the challenges of living with Parkinson disease through active participation in walking and other movement activities."

People who take part in Moving Day® become part of a nationwide movement to beat PD by supporting disease education and outreach, cutting-edge research aimed at better treatment and care for PD patients, advancement of clinical care through healthcare professional training, and raising general awareness about the disease. Moving Day ® promotes awareness of Parkinson's both nationally and in the Tampa Bay area. Proceeds raised from the campaign go toward supporting local services for people living with the disease and research leading to better treatments. 

Each walk will feature a "Movement Pavilion," with activities such as yoga, Pilates, Tai Chi, dance and much more. Studies show that movement is beneficial and proven to help manage the symptoms of PD, improving flexibility and mobility. The aim is to encourage people to stay active and move for better health. 

"It is my hope that bringing Moving Day ® to the Tampa Bay area will raise awareness in the community of the critical needs of their neighbors, including those in the Parkinson's community," said Bob Sheehan, PD patient and Event Chair.

To learn more about Moving Day ® and how you, your family and friends, and/or your company can get involved, please visit Moving Day® is made possible through the generous support of our National Moving Day ® Partners: Lundbeck, US WorldMeds, UCB and Right at Home. Additional national and local sponsorship opportunities are available.

About Parkinson's Disease
Parkinson's disease is a neurodegenerative brain disorder that progresses slowly in most people with PD. When 60 to 80 percent of the dopamine-producing cells in the brain are damaged, and do not produce enough dopamine, the motor symptoms of PD appear. In the United States, 60,000 new cases are diagnosed each year, adding to the one million people who have Parkinson's disease.  It is estimated that four to six million people around the world have Parkinson's.

For more information about the National Parkinson Foundation, please visit or call 1-800-4PD-INFO (473-4636). For more information about Moving Day ® Tampa Bay and to register your walk team, visit

Monday, March 16, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.


mail icon

Subscribe to get the latest news on treatments, research and other updates.